Daniel Fekade

882 total citations
27 papers, 559 citations indexed

About

Daniel Fekade is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Daniel Fekade has authored 27 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Daniel Fekade's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (7 papers). Daniel Fekade is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (7 papers). Daniel Fekade collaborates with scholars based in Ethiopia, Sweden and United Kingdom. Daniel Fekade's co-authors include David G. Lalloo, Ruth Coxon, Kyle Knox, Kebede Hussein, Yeweyenhareg Feleke, David J. Wright, Sally J. Cutler, David A. Warrell, Anders Sönnerborg and Gaetano Marrone and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Daniel Fekade

27 papers receiving 544 citations

Peers

Daniel Fekade

EPIDE

PARAS

VIROL

PHEOH

Alaaddin Pahsa Türkiye

Patrick E. Olson United States

M. Chakroun Tunisia

Dora Estripeaut Panama

Maurizio Gulletta Italy

Francisco Reyes Spain

Majid Yaran Iran

Adriana Pistol Romania

Bernard Marcel Diop Senegal

Walter de Araújo Eyer-Silva Brazil

Alaaddin Pahsa Türkiye

Daniel Fekade

268 ×0.8

220 ×1.2

EPIDE

95 ×0.6

PARAS

26 ×0.3

VIROL

85 ×1.0

PHEOH

Citations per year, relative to Daniel Fekade Daniel Fekade (= 1×) peers Alaaddin Pahsa

Countries citing papers authored by Daniel Fekade

Since Specialization

Citations

This map shows the geographic impact of Daniel Fekade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Fekade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Fekade more than expected).

Fields of papers citing papers by Daniel Fekade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Fekade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Fekade. The network helps show where Daniel Fekade may publish in the future.

Co-authorship network of co-authors of Daniel Fekade

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Fekade. A scholar is included among the top collaborators of Daniel Fekade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Fekade. Daniel Fekade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gebre-Selassie, Solomon, Daniel Fekade, Gaetano Marrone, et al.. (2019). A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort. BMC Infectious Diseases. 19(1). 569–569. 6 indexed citations

Gebre-Selassie, Solomon, Daniel Fekade, Samir Abdurahman, et al.. (2018). Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing. Scientific Reports. 8(1). 7556–7556. 26 indexed citations

Marrone, Gaetano, et al.. (2018). Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PLoS ONE. 13(7). e0200505–e0200505. 26 indexed citations

Fekade, Daniel, et al.. (2017). Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses–an analysis of a prospective country-wide cohort. BMC Infectious Diseases. 17(1). 37–37. 9 indexed citations

Fekade, Daniel, et al.. (2017). Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort. PLoS ONE. 12(8). e0182384–e0182384. 2 indexed citations

Fekade, Daniel, Teklu Weldegebreal, Alula M. Teklu, et al.. (2017). Predictors of survival among adult Ethiopian patients in the national ART program at Seven University Teaching Hospitals: A prospective cohort study. Ethiopian Journal of Health Sciences. 27(1). 63–63. 21 indexed citations

Teklu, Alula M., Daniel Fekade, William Weiss, et al.. (2017). Establishing a multicenter longitudinal clinical cohort Study in Ethiopia: Advanced Clinical Monitoring of Antiretroviral Treatment Project. Ethiopian Journal of Health Sciences. 27(1). 3–3. 4 indexed citations

Tenna, Admasu, et al.. (2014). No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia. PLoS ONE. 9(1). e85698–e85698. 3 indexed citations

Derbew, Miliard, et al.. (2014). Turnover rate of academic faculty at the College of Health Sciences, Addis Ababa University: A 20-year analysis (1991-2011). Annals of Global Health. 80(3). 236–236. 3 indexed citations

10.

Kempker, Russell R., Admasu Tenna, Nega Berhe, et al.. (2013). High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia. PLoS ONE. 8(3). e58377–e58377. 55 indexed citations

11.

Hailu, Alemayehu, Damen Haile Mariam, Daniel Fekade, Miliard Derbew, & Amha Mekasha. (2013). Turn-over rate of academic faculty at the College of Health Sciences, Addis Ababa University: a 20-year analysis (1991 to 2011). Human Resources for Health. 11(1). 61–61. 12 indexed citations

12.

Diro, Ermias, et al.. (2009). Assessment of risk behaviours and factors associated with oral and peri-oral lesions in adult HIV patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiopian Journal of Health Development. 22(2). 5 indexed citations

13.

Davey, Gail, Daniel Fekade, & Eldryd Parry. (2006). Must aid hinder attempts to reach the Millennium Development Goals?. The Lancet. 367(9511). 629–631. 12 indexed citations

14.

Cooper, Philip J., et al.. (2000). Recombinant Human Interleukin‐10 Fails to Alter Proinflammatory Cytokine Production or Physiologic Changes Associated with the Jarisch‐Herxheimer Reaction. The Journal of Infectious Diseases. 181(1). 203–209. 30 indexed citations

15.

Vidal, Vincent, Ian G. Scragg, Sally J. Cutler, et al.. (1998). Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nature Medicine. 4(12). 1416–1420. 46 indexed citations

16.

Cutler, Sally J., J. Moss, M Fukunaga, et al.. (1997). Borrelia recurrentis Characterization and Comparison with Relapsing-Fever, Lyme-Associated, and Other Borrelia spp.. International Journal of Systematic Bacteriology. 47(4). 958–968. 48 indexed citations

17.

Remick, Daniel G., et al.. (1996). Pentoxifylline Fails to Prevent the Jarisch-Herxheimer Reaction or Associated Cytokine Release. The Journal of Infectious Diseases. 174(3). 627–630. 14 indexed citations

18.

Fekade, Daniel, et al.. (1996). Prevention of Jarisch–Herxheimer Reactions by Treatment with Antibodies against Tumor Necrosis Factor α. New England Journal of Medicine. 335(5). 311–315. 127 indexed citations

19.

Bjorvatn, Bjarne, et al.. (1992). DNA Fingerprinting in the Epidemiology of African Serogroup A Neisseria meningitidis. Scandinavian Journal of Infectious Diseases. 24(3). 323–332. 12 indexed citations

20.

Fekade, Daniel. (1989). Histopathological features of liver disease in hospitalized Ethiopian patients.. PubMed. 27(1). 9–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact